Literature DB >> 17484226

Infant botulism and treatment with BIG-IV (BabyBIG).

Sarah S Long1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17484226     DOI： 10.1097/01.inf.0000256442.06231.17

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  7 in total

1.  Recombinant holotoxoid vaccine against botulism.

Authors:  Christina L Pier; William H Tepp; Marite Bradshaw; Eric A Johnson; Joseph T Barbieri; Michael R Baldwin
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

2.  Genomic Epidemiology of Clostridium botulinum Isolates from Temporally Related Cases of Infant Botulism in New South Wales, Australia.

Authors:  Nadine McCallum; Timothy J Gray; Qinning Wang; Jimmy Ng; Leanne Hicks; Trang Nguyen; Marion Yuen; Grant A Hill-Cawthorne; Vitali Sintchenko
Journal:  J Clin Microbiol       Date:  2015-06-24       Impact factor: 5.948

3.  Equine botulinum antitoxin for the treatment of infant botulism.

Authors:  Elida E Vanella de Cuetos; Rafael A Fernandez; María I Bianco; Omar J Sartori; María L Piovano; Carolina Lúquez; Laura I T de Jong
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

4.  Abnormal Neuroimaging in a Case of Infant Botulism.

Authors:  Ryan J Good; Kevin Messacar; Nicholas V Stence; Craig A Press; Todd C Carpenter
Journal:  Front Pediatr       Date:  2015-12-11       Impact factor: 3.418

5.  Attomolar detection of botulinum toxin type A in complex biological matrices.

Authors:  Karine Bagramyan; Jason R Barash; Stephen S Arnon; Markus Kalkum
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

6.  Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E.

Authors:  Sebastian Miethe; Christine Rasetti-Escargueil; Arnaud Avril; Yvonne Liu; Siham Chahboun; Hannu Korkeala; Christelle Mazuet; Michel-Robert Popoff; Thibaut Pelat; Philippe Thullier; Dorothea Sesardic; Michael Hust
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

7.  Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.

Authors:  Sebastian Miethe; Christelle Mazuet; Yvonne Liu; Robert Tierney; Christine Rasetti-Escargueil; Arnaud Avril; André Frenzel; Philippe Thullier; Thibaut Pelat; Remi Urbain; Alexandre Fontayne; Dorothea Sesardic; Michael Hust; Michel Robert Popoff
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.